HCT-15 Cells

HCT-15 cells are derived from the adenocarcinoma of the colon of a 44-year-old Caucasian male. This cell line, developed in the early 1970s, is widely utilized in the field of cancer research, especially for exploring the biology and treatment of colorectal cancer.
Morphologically, HCT-15 cells are characterized by an epithelial-like appearance with a tendency to grow both as a monolayer and in clusters, displaying significant cellular heterogeneity. This feature mirrors the varied cellular environments found in solid tumors, making HCT-15 a valuable model for studying tumor dynamics and cellular interactions within the tumor microenvironment.
Genotypically, HCT-15 cells exhibit a hyperdiploid karyotype with multiple chromosomal aberrations, typical of many colorectal cancers. These include mutations in key oncogenes and tumor suppressor genes, such as mutations in the KRAS gene and deletions affecting the p53 pathway, which are implicated in the pathogenesis and progression of colorectal cancer. These genetic traits make HCT-15 cells a crucial tool for investigating genetic and molecular mechanisms associated with cancer progression, metastasis, and resistance to therapies.
The broad use of HCT-15 cells in research has led to significant insights into the molecular pathways involved in colorectal cancer, enhancing our understanding of disease mechanisms and aiding in the development of targeted therapies.